Vaccinex, Inc. (VCNX) Free cash flow 2017–2024
Vaccinex, Inc. (VCNX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.2MFY2024 · since FY2017: -$21.5M → -$16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.2M | +24.4% |
| FY2023 | -$21.4M | -11.9% |
| FY2022 | -$19.2M | +24.3% |
| FY2021 | -$25.3M | +12.5% |
| FY2020 | -$28.9M | +6.0% |
| FY2019 | -$30.8M | -20.7% |
| FY2018 | -$25.5M | -18.9% |
| FY2017 | -$21.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Gross marginVCNX Operating incomeVCNX Operating marginVCNX Operating cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →